Milestone Pharmaceuticals (MIST) Current Assets (2018 - 2026)

Milestone Pharmaceuticals (MIST) has reported Current Assets for 9 consecutive years, with $180.3 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Current Assets rose 290.59% year-over-year to $180.3 million; the trailing twelve-month figure through Jun 2026 stood at $180.3 million (up 290.59% YoY), and the FY2025 full-year result was $111.9 million, up 51.4% from the prior year.
• Current Assets retreated to $180.3 million in Q2 2026 per MIST's latest filing, from $192.3 million in the prior quarter.
• Across five years, Current Assets topped out at $192.3 million in Q1 2026 and bottomed at $46.2 million in Q2 2025.
• Historically, Current Assets has averaged $95.8 million across 5 years, with a median of $87.0 million in 2024.
• The sharpest annual moves came in 2025 and 2026: Current Assets slumped 47.15% in 2025, then surged 290.59% in 2026.
• Over 5 years, Current Assets stood at $71.8 million in 2022, then grew by 1.71% to $73.0 million in 2023, then gained by 1.22% to $73.9 million in 2024, then jumped by 51.4% to $111.9 million in 2025, then soared by 61.12% to $180.3 million in 2026.
• According to Business Quant data, Current Assets over the past three periods registered $180.3 million, $192.3 million, and $111.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.